Drug factory · FDA FEI 3002807151
HAS Healthcare Advanced Synthesis SA
Via Industria 24, Biasca, Switzerland
No problems found at FDA's last inspection, Feb 20, 2025.
No Action Indicated: inspectors found no objectionable conditions.
4 drug inspections on record since 2012: 4 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Bosentan | Makes the active ingredient and tests it | Actelion Pharmaceuticals US, Inc. | 66215-101, 66215-102, 66215-232 |
| Dantrolene | Makes the active ingredient | Uswm, LLC | 78670-003 |
| Fosnetupitant and Palonosetron | Makes the active ingredient | Helsinn Therapeutics (U.S.), Inc. | 69639-102, 69639-105, 69639-106 |
| Lofexidine | Makes the active ingredient and tests it | Uswm, LLC | 78670-050 |
| Netupitant and Palonosetron | Makes the active ingredient | Helsinn Therapeutics (U.S.), Inc. | 69639-101 |
| Palonosetron | Makes the active ingredient | Cipla USA., Inc. | 69097-927 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 20, 2025 | No problems found | Drug Quality Assurance | — |
| May 4, 2018 | No problems found | Drug Quality Assurance | — |
| Apr 11, 2014 | No problems found | Drug Quality Assurance | — |
| Apr 4, 2012 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; manufacture.